INS and diabetes mellitus: Oral glucose tolerance testing is routinely performed prior to islet autotransplant to confirm absence of diabetes and to evaluate islet cell reserve with loss of first-phase (elevated 1-hour glucose) and/or second-phase insulin secretion (elevated 2-hour glucose) indicative of loss of islet cell mass and hence likelihood of needing insulin therapy despite islet cell transplantation.